authors
- Lathouwers E
- De Meyer S
- AMBER and EMERALD Study Groups
- Wong EY
- Brown K
- Baugh B
- Ghys A
- Jezorwski J
- Mohsine EG
- GUTIERREZ RODERO, FELIX
- Mohsine EG
- PORTILLA SOGORB, JOAQUIN
- Opsomer M
Week 48 Resistance Analyses of the Once-Daily, Single-Tablet Regimen Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) in Adults Living with HIV-1 from the Phase III Randomized AMBER and EMERALD Trials
Academic Article
2019
- Overview
- Additional Document Info
- Otro
- Ver todos